Dr. Pakola is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Regenxbio
Irvington, NY 10533
Education & Training
- Perelman School of Medicine at the University of PennsylvaniaClass of 1994
Certifications & Licensure
- NC State Medical License 1997 - 2022
Publications & Presentations
PubMed
- 23 citationsAssociation between anatomical resolution and functional outcomes in the mivi-trust studies using ocriplasmin to treat symptomatic vitreomacular adhesion/vitreomacular...Arnd Gandorfer, Matthew S. Benz, Julia A. Haller, Peter Stalmans, Stephen Pakola
Retina. 2015-06-01 - 110 citationsEfficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion: Subgroup Analyses from Two Randomized TrialsJulia A. Haller, Peter Stalmans, Matthew S. Benz, Arnd Gandorfer, Stephen Pakola
Ophthalmology. 2015-01-01 - 31 citationsLocalization of Traumatic Oculomotor Nerve Palsy to the Midbrain Exit Site by Magnetic Resonance ImagingLaura J. Balcer, Steven Galetta, Linda J. Bagley, Stephen J. Pakola
American Journal of Ophthalmology. 1996-09-01
Press Mentions
- REGENXBIO Reports Third Quarter 2019 Financial and Operating Results and Recent Operational HighlightsNovember 26th, 2019
- REGENXBIO Reports First Quarter 2019 Financial and Operating Results and Additional Positive Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMDMay 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: